Active ocular toxoplasmosis in Turkish patients: A report on 109 cases

International Ophthalmology

Volumn 26, Issue 6, 2005, Pages 221-228

  Tugal Tutkun, Ilknur ^a   Corum, Isik ^a   Ötük, Berna ^a   Urgancioglu, Meri ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Ocular toxoplasmosis; Recurrence risk; Visual acuity

Indexed keywords

ANTIPARASITIC AGENT; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; FOLINIC ACID; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PYRIMETHAMINE; SPIRAMYCIN; TRIAMCINOLONE;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CHORIORETINITIS; CLINICAL FEATURE; DRUG INDICATION; DRUG INTERMITTENT THERAPY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EYE INFECTION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRIDOCYCLITIS; KAPLAN MEIER METHOD; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHLEBITIS; PROGNOSIS; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TOXOPLASMA GONDII; TOXOPLASMOSIS; TURKEY (REPUBLIC); VISUAL ACUITY; VISUAL SYSTEM EXAMINATION; VITRECTOMY; VITREOUS DISEASE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIPROTOZOAL AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; TOXOPLASMA; TOXOPLASMOSIS, OCULAR; TURKEY; VISUAL ACUITY;

EID: 33947192881     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-007-9047-8     Document Type: Article

References (30)

1. Holland GN (2003) LX Edward Jackson memorial lecture. Ocular toxoplasmosis: A global rEassessment. Part I: epidemiology and course of disease. Am J Ophthalmol 136:973-988
2. Yolasigmaz A, Sakru N, Yazar S et al (2003) Investigation of anti-toxoplasma antibodies in residence of urban and rural areas. Acta Parasitologica Turcica 27:81-84
3. Ertug S, Okyay P, Turkmen M, Yuksel H (2005) Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin Province, Turkey. BMC Public Health 5:66-71
4. Harma M, Harma M, Gungen N, Demir N (2004) Toxoplasmosis in pregnant women in Sanliurfa, Southeastern Anatolia city, Turkey. J Egypt Soc Parasitol 34:519-525
5. Sengun A, Karadag R, Karakurt A et al (2005) Causes of uveitis in a referral hospital in Ankara, Turkey. Ocul Immunol Inflamm 13:45-50
6. Soylu M, Ozdemir G, Anli A (1997) Pediatric uveitis in southern Turkey. Ocul Immunol Inflamm 5:197-202
7. Atmaca LS, Simsek T, Batioglu F (2004) Clinical features and prognosis in ocular toxoplasmosis. Jpn J Ophthalmol 48:386-391
8. Bosch-Driessen LEH, Berendschot TTJM, Ongkosuwito JV, Rothova A (2002) Ocular toxoplasmosis. Clinical features and prognosis of 154 patients. Am J Ophthalmol 109:869-878
9. Burnett AJ, Shortt SG, Isaac-Renton J et al (1998) Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 105:1032-1037
10. Holland GN, O'Connor GR, Belfort R Jr., Remington JS (1996) Toxoplasmosis. In: Pepose JS, Holland GN, Wilhelmus KR (eds) Ocular infection and immunity. Mosby, St. Louis, pp 1183-1223
11. Mets MB, Holfels E, Boyer KM et al (1996) Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 122:309-322
12. Silveira C, Belfort R, Muccioli C et al (2001) A follow-up study of Toxoplasma gondii infection in Southern Brazil. Am J Ophthalmol 131:351-354
13. Holland GN (2000) Ocular toxoplasmosis: New directions for clinical investigation. Ocul Immunol Inflamm 8:1-7
14. Holland GN, Muccioli C, Silveira C et al (1999) Intraocular inflammatory reactions without necrotizing retinochoroiditis in patients with acquired systemic toxoplasmosis. Am J Ophthalmol 128:413-420
15. Bosch-Driessen EH, Rothova A (1999) Recurrent ocular disease in postnatally acquired toxoplasmosis. Am J Ophthalmol 128:421-425
16. Friedman CT, Knox DL (1969) Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 81:481-493
17. Stanford MR, Gras L, Wade A, Gilbert RE (2002) Reliability of expert interpretation of retinal photographs for the diagnosis of toxoplasma retinochoroiditis. Br J Ophthalmol 86:636-639
18. Ronday MJH, Luyendijk L, Baarsma GS et al (1995) Presumed acquired ocular toxoplasmosis. Arch Ophthalmol 113:1524-1529
19. Fardeau C, Romand S, Rao NA et al (2002) Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol 134:196-203
20. Moshfeghi DM, Dodds EM, Couto CA et al (2004) Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis. Ophthalmology 111:716-725
21. Labalette P, Delhaes L, Margaron F et al (2002) Ocular toxoplasmosis after the fifth decade. Am J Ophthalmol 133:506-515
22. Johnson MW, Greven CM, Jaffe GJ et al (1997) Atypical, severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology 104:48-57
23. Holland GN (2004) LX Edward Jackson memorial lecture. Ocular toxoplasmosis: A global reDssessment. Part II: disease manifestations and management. Am J Ophthalmol 137:1-17
24. Schlaegel TF, Weber JC (1984) The macula in ocular toxoplasmosis. Arch Ophthalmol 102:697-698
25. Westfall AC, Lauer AK, Suhler EB, Rosenbaum JT (2005) Toxoplasmosis retinochoroiditis and elevated intraocular pressure: A retrospective study. J Glaucoma 14:3-10
26. Theodossiadis P, Kokolakis S, Ladas I et al (1995) Retinal vascular involvement in acute toxopalsmic retinochoroiditis. Intern Ophthalmol 19:19-24
27. Atmaca LS, Simsek G, Sonmez PA, Sonmez K (2006) Fluorescein and indocyanine green angiography in ocular toxoplasmosis. Graefes Arch Clin Exp Ophthalmol 244:1688-1691
28. Auer C, Bernasconi O, Herbort CP (1999) Indocyanine green angiography features in toxoplasmic retinochoroiditis. Retina 19:22-19
29. Aggio FB, Muccioli C, Belfort R (2005) Intravitreal triamcinolone acetonide as an adjuct in the treatment of severe ocular toxoplasmosis. Eye 20:1080-1082
30. Silveira C, Belfort R, Muccioli C et al (2002) The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 134:41-46